Neonatal Jaundice and the Developing Brain: Pathophysiology, Clinical Management, and Long-Term Neurological Outcome
SVOA Neurology · 01.06.2026 · 7 (3) · 107-123
DOI: 10.58624/svoane.2026.07.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift SVOA Neurology, online erschienen am 01.06.2026. Verfasst von Damilare Alabi Akanbi und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Neonatal jaundice, characterized by elevated serum bilirubin levels, is a common condition affecting newborns globally. While mild jaundice is often benign, severe hyperbilirubinemia poses a significant risk to neurological development. If left untreated, it can lead to irreversible brain damage, with lifelong implications for affected children. This review aims to examine the impact of neonatal jaundice on pediatric neurological outcomes, focusing on the pathophysiology, risk factors, clinical manifestations, and long-term consequences. A comprehensive analysis of current literature was conducted, including clinical studies and systematic reviews. Emphasis was placed on understanding the neurological sequelae of neonatal jaundice and evaluating the effectiveness of therapeutic interventions. Findings indicate that severe neonatal jaundice is associated with neurological complications such as acute bilirubin encephalopathy and kernicterus. These conditions can result in motor impairments, hearing loss, speech delays, and cognitive dysfunction. Early diagnosis and interventions, such as phototherapy and exchange transfusion, have significantly reduced the incidence of severe outcomes. However, in low-resource settings, delayed diagnosis and inadequate treatment remain substantial challenges, increasing the risk of permanent disability. Neonatal jaundice, if improperly managed, poses serious risks to pediatric neurological health. Timely intervention and improved screening protocols are essential to prevent long-term neurological damage. Further research is needed to explore the subtle neurodevelopmental effects and to enhance care strategies, especially in under-resourced regions. A multidisciplinary approach is crucial to mitigate these risks and improve outcomes for affected children.
Zitieren
APA
Akanbi, D. A., Nkwocha, I. B., Akinyemi, D., Ogunwale, E. T., Aremu, I. G., Ogunlola, M. W., & Olowolagba, O. D. (2026). Neonatal Jaundice and the Developing Brain: Pathophysiology, Clinical Management, and Long-Term Neurological Outcome. SVOA Neurology, 7(3), 107-123. https://doi.org/10.58624/svoane.2026.07.016
Vancouver
Akanbi DA, Nkwocha IB, Akinyemi D, Ogunwale ET, Aremu IG, Ogunlola MW, et al. Neonatal Jaundice and the Developing Brain: Pathophysiology, Clinical Management, and Long-Term Neurological Outcome. SVOA Neurology. 2026;7(3):107-123. doi:10.58624/svoane.2026.07.016
BibTeX
@article{Akanbi2026,
author = {Akanbi, Damilare Alabi and Nkwocha, Ifeoma Bianca and Akinyemi, David and Ogunwale, Esther Timileyin and Aremu, Iyanuoluwa Gladys and Ogunlola, Merylin Wuraola and Olowolagba, Oluwayemisi Deborah},
title = {Neonatal Jaundice and the Developing Brain: Pathophysiology, Clinical Management, and Long-Term Neurological Outcome},
journal = {SVOA Neurology},
year = {2026},
volume = {7},
number = {3},
pages = {107--123},
doi = {10.58624/svoane.2026.07.016}
}
EUVIMED